{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:51:05Z","timestamp":1790743865196,"version":"4.1.0"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Notable advances in gene sequencing methods in recent years have permitted enormous progress in the phenotypic and genotypic characterization of autoinflammatory syndromes. Interferonopathies are a recent group of inherited autoinflammatory diseases, characterized by a dysregulation of the interferon pathway, leading to constitutive upregulation of its activation mechanisms or downregulation of negative regulatory systems. They are clinically heterogeneous, but some peculiar clinical features may lead to suspicion: a familial \u201cidiopathic\u201d juvenile arthritis resistant to conventional treatments, an early necrotizing vasculitis, a non-infectious interstitial lung disease, and a panniculitis associated or not with a lipodystrophy may represent the \u201cinterferon alarm bells.\u201d The awareness of this group of diseases represents a challenge for pediatricians because, despite being rare, a differential diagnosis with the most common childhood rheumatological and immunological disorders is mandatory. Furthermore, the characterization of interferonopathy molecular pathogenetic mechanisms is allowing important steps forward in other immune dysregulation diseases, such as systemic lupus erythematosus and inflammatory myositis, implementing the opportunity of a more effective target therapy.<\/jats:p>","DOI":"10.3389\/fped.2021.631329","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T04:34:17Z","timestamp":1617165257000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":76,"title":["Type I Interferonopathies in Children: An Overview"],"prefix":"10.3389","volume":"9","author":[{"given":"Debora M.","family":"d'Angelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Di Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Breda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apcsb.2019.11.001","article-title":"The expanding pathways of autoinflammation: a lesson from the first 100 genes related to autoinflammatory manifestations","volume":"120","author":"Papa","year":"2020","journal-title":"Adv Protein Chem Struct Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12969-016-0094-4","article-title":"Type I interferonopathies in pediatric rheumatology","volume":"14","author":"Volpi","year":"2016","journal-title":"Rheumatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/jmg.40.3.183","article-title":"Cree encephalitis is allelic with Aicardi-Gouti\u00e8res syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism","volume":"40","author":"Crow","year":"2003","journal-title":"J Med Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview","volume":"213","author":"Rodero","year":"2016","journal-title":"J Exp Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ng.373","article-title":"Mutations involved in Aicardi-Gouti\u00e8res syndrome implicate SAMHD1 as regulator of the innate immune response","volume":"41","author":"Rice","year":"2009","journal-title":"Nat Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/ng1845","article-title":"Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Gouti\u00e8res syndrome at the AGS1 locus","volume":"38","author":"Crow","year":"2006","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1089\/jir.2011.0045","article-title":"Type I interferon and systemic lupus erythematosus","volume":"31","author":"Elkon","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","article-title":"Type I interferonopathies: a novel set of inborn errors of immunity","volume":"1238","author":"Crow","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.berh.2017.12.002","article-title":"Genetic interferonopathies: an overview","volume":"31","author":"Eleftheriou","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2014.10.005","article-title":"Type I interferonopathies: mendelian type I interferon up-regulation","volume":"32","author":"Crow","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11926-018-0748-y","article-title":"An update on autoinflammatory diseases: interferonopathies","volume":"20","author":"Davidson","year":"2018","journal-title":"Curr Rheumatol Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"a028423","DOI":"10.1101\/cshperspect.a028423","article-title":"The interferon (IFN) class of cytokines and the IFN regulatory factor (IRF) transcription factor family","volume":"10","author":"Negishi","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.immuni.2012.01.011","article-title":"Constitutive type I interferon modulates homeostatic balance through tonic signaling","volume":"36","author":"Gough","year":"2012","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.5483\/BMBRep.2004.37.6.635","article-title":"Mechanisms of type-I interferon signal transduction","volume":"37","author":"Uddin","year":"2004","journal-title":"J Biochem Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2796.2008.02050.x","article-title":"Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications","volume":"265","author":"Guiducci","year":"2009","journal-title":"J Intern Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Ann Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1084\/jem.20180139","article-title":"The cGAS\u2013cGAMP\u2013STING pathway connects DNA damage to inflammation, senescence, and cancer","volume":"215","author":"Li","year":"2018","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.chom.2015.07.001","article-title":"STING activation by translocation from the ER is associated with infection and autoinflammatory disease","volume":"18","author":"Dobbs","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fimmu.2014.00342","article-title":"Pattern recognition and signaling mechanisms of RIG-I and MDA5","volume":"5","author":"Reikine","year":"2014","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3389\/fimmu.2018.01135","article-title":"A positive feedback amplifier circuit that regulates interferon (IFN)-stimulated gene expression and controls type I and type II IFN responses","volume":"28","author":"Michalska","year":"2018","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature13801","article-title":"Human intracellular ISG15 prevents interferon-alpha\/beta over-amplification and auto-inflammation","volume":"517","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cyto.2015.03.006","article-title":"ISG15 uncut: dissecting enzymatic and non-enzymatic functions of USP18 in vivo","volume":"76","author":"Ketscher","year":"2015","journal-title":"Cytokine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.1074\/jbc.R116.774562","article-title":"The molecular basis for differential type I interferon signaling","volume":"292","author":"Schreiber","year":"2017","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41588-020-00737-3","article-title":"cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing","volume":"52","author":"Uggenti","year":"2020","journal-title":"Nat Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.conb.2015.09.003","article-title":"Fine-tuning of type I IFN-signaling in microglia-implications for homeostasis, CNS autoimmunity and interferonopathies","volume":"36","author":"Goldmann","year":"2016","journal-title":"Curr Opin Neurobiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1007\/s11064-017-2307-8","article-title":"Microglial interferon signaling and white matter","volume":"42","author":"McDonough","year":"2017","journal-title":"Neurochem Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.1523\/JNEUROSCI.0203-12.2012","article-title":"Toll\/interleukin-1 receptor domain-containing adapter inducing interferon-beta mediates microglial phagocytosis of degenerating axons","volume":"32","author":"Hosmane","year":"2012","journal-title":"J Neurosci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/dvdy.1","article-title":"Developmental roles of microglia: a window into mechanisms of disease","volume":"248","author":"Anderson","year":"2019","journal-title":"Dev Dyn."},{"key":"B33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.immuni.2008.03.011","article-title":"Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system","volume":"28","author":"Prinz","year":"2008","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/01.WCB.0000080703.47016.B6","article-title":"Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat","volume":"23","author":"Veldhuis","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12974-015-0427-0","article-title":"Endogenous IFN-beta signaling exerts anti-inflammatory actions in experimentally induced focal cerebral ischemia","volume":"12","author":"Inacio","year":"2015","journal-title":"J Neuroinflammation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","article-title":"Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke","volume":"316","author":"Yang","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"11030","DOI":"10.1128\/MCB.25.24.11030-11034.2005","article-title":"Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice","volume":"25","author":"Knobeloch","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40478-019-0757-8","article-title":"Loss of USP18 in microglia induces white matter pathology","volume":"7","author":"Schwabenland","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.20151529","article-title":"Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome","volume":"213","author":"Meuwissen","year":"2016","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1055\/s-0034-1389161","article-title":"Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia","volume":"45","author":"Crow","year":"2014","journal-title":"Neuropediatrics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ebiom.2019.09.059","article-title":"Interferon-\u03b2 corrects massive gene dysregulation in multiple sclerosis: short-term and long-term effects on immune regulation and neuroprotection","volume":"49","author":"Feng","year":"2019","journal-title":"EBioMedicine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12974-019-1639-5","article-title":"Type I interferon (IFN)-inducible Absent in Melanoma 2 proteins in neuroinflammation: implications for Alzheimer's disease","volume":"16","author":"Choubey","year":"2019","journal-title":"J Neuroinflammation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12519-019-00273-z","article-title":"Toward a better understanding of type I interferonopathies: a brief summary, update and beyond","volume":"16","author":"Yu","year":"2020","journal-title":"World J Pediatr"},{"key":"B45","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1055\/s-0036-1592307","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAM HD1, ADAR, and IFIH1","volume":"167","author":"Crow","year":"2015","journal-title":"Am J Med Genet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","article-title":"Assessment of interferon-related biomarkers in Aicardi-Gouti\u00e8res syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study","volume":"12","author":"Rice","year":"2013","journal-title":"Lancet Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3389\/fimmu.2020.00985","article-title":"Interstitial lung disease and psoriasis in a child with Aicardi-Gouti\u00e8res syndrome","volume":"11","author":"Zheng","year":"2020","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.4049\/jimmunol.1401334","article-title":"Phenotypic variation in Aicardi-Gouti\u00e8res syndrome explained by cell-specific IFN-stimulated gene response and cytokine release","volume":"194","author":"Cuadrado","year":"2015","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1093\/hmg\/ddp293","article-title":"Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity","volume":"18","author":"Crow","year":"2009","journal-title":"Hum Mol Genet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41586-018-0050-1","article-title":"SAMHD1 acts at stalled replication forks to prevent interferon induction","volume":"557","author":"Coquel","year":"2018","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/521373","article-title":"Clinical and molecular phenotype of Aicardi-Goutieres syndrome","volume":"81","author":"Rice","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.heares.2011.08.004","article-title":"Early age conductive hearing loss causes audiogenic seizure and hyperacusis behavior","volume":"282","author":"Sun","year":"2011","journal-title":"Hear Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejpn.2013.07.005","article-title":"Epilepsy in Aicardi-Gouti\u00e8res syndrome","volume":"18","author":"Ramantani","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/humu.21357","article-title":"Cerebral arterial stenoses and stroke: novel features of Aicardi-Gouti\u00e8res syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expression","volume":"31","author":"Thiele","year":"2010","journal-title":"Hum Mutat"},{"key":"B56","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10875-016-0325-y","article-title":"Exploring autoimmunity in a cohort of children with genetically confirmed Aicardi-Gouti\u00e8res syndrome","volume":"36","author":"Cattalini","year":"2016","journal-title":"J Clin Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/ajmg.a.33359","article-title":"Familial Aicardi-Gouti\u00e8res syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures","volume":"152","author":"Dale","year":"2010","journal-title":"Am J Med Genet A"},{"key":"B58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/ng.748","article-title":"Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature","volume":"43","author":"Briggs","year":"2011","journal-title":"Nat Genet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ng.749","article-title":"Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity","volume":"43","author":"Lausch","year":"2011","journal-title":"Nat Genet"},{"key":"B60","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/ni1327","article-title":"Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells","volume":"7","author":"Shinohara","year":"2006","journal-title":"Nat Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1177\/0961203316629000","article-title":"Three cases of spondyloenchondrodysplasia (SPENCD) with systemic lupus erythematosus: a case series and review of the literature","volume":"25","author":"Bilginer","year":"2016","journal-title":"Lupus"},{"key":"B62","first-page":"562","article-title":"Serum levels of interferons in patients with systemic lupus erythematosus","volume":"70","author":"Kim","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci Transl Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B65","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/sj.gene.6364408","article-title":"High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus","volume":"8","author":"Niewold","year":"2007","journal-title":"Genes Immun"},{"key":"B67","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of human systemic lupus erythematosus: a cellular perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaut.2015.08.004","article-title":"Immunogenetics of systemic lupus erythematosus: a comprehensive review","volume":"64","author":"Ghodke-Puranik","year":"2015","journal-title":"J Autoimmun"},{"key":"B69","doi-asserted-by":"publisher","first-page":"102361","DOI":"10.1016\/j.autrev.2019.102361","article-title":"Monogenic lupus: dissecting heterogeneity","volume":"18","author":"Omarjee","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3389\/fimmu.2018.02496","article-title":"Monogenic lupus: a developing paradigm of disease","volume":"9","author":"Alperin","year":"2018","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/jcm9030712","article-title":"New horizons in the genetic etiology of systemic lupus erythematosus and lupus-like disease: monogenic lupus and beyond","volume":"5","author":"Demirkaya","year":"2020","journal-title":"J Clin Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1002\/art.24852","article-title":"C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis","volume":"60","author":"Lood","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/art.40158","article-title":"Brief report: deficiency of complement 1r subcomponent in early-onset systemic lupus erythematosus: the role of disease-modifying alleles in a monogenic disease","volume":"69","author":"Demirkaya","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/76032","article-title":"Features of systemic lupus erythematosus in Dnase1-deficient mice","volume":"25","author":"Napirei","year":"2000","journal-title":"Nat Genet"},{"key":"B75","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/91070","article-title":"Mutation of DNASE1 in people with systemic lupus erythematosus","volume":"28","author":"Yasutomo","year":"2001","journal-title":"Nat Genet"},{"key":"B76","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.autrev.2008.02.002","article-title":"DNase 1 and systemic lupus erythematosus","volume":"7","author":"Mart\u00ednez Valle","year":"2008","journal-title":"Autoimmun Rev"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/ng.975","article-title":"Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus","volume":"43","author":"Al-Mayouf","year":"2011","journal-title":"Nat Genet"},{"key":"B78","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cell.2016.05.034","article-title":"Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity","volume":"166","author":"Sisirak","year":"2016","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21037\/jxym.2017.03.03","article-title":"Targeting the extracellular scavenger DNASE1L3 on SLE","volume":"2","author":"Wang","year":"2017","journal-title":"J Xiangya Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41467-017-01932-3","article-title":"Type I interferon-mediated autoinflammation due to DNase II deficiency","volume":"8","author":"Rodero","year":"2017","journal-title":"Nat Commun"},{"key":"B81","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1086\/507848","article-title":"Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p","volume":"79","author":"Lee-Kirsch","year":"2006","journal-title":"Am J Hum Genet"},{"key":"B82","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1086\/513443","article-title":"Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi- Goutieres syndrome","volume":"80","author":"Rice","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10875-015-0147-3","article-title":"Human disease phenotypes associated with mutations in TREX1","volume":"35","author":"Rice","year":"2015","journal-title":"J Clin Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/gene.2010.73","article-title":"Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort","volume":"12","author":"Namjou","year":"2011","journal-title":"Genes Immun"},{"key":"B85","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.rdc.2017.04.005","article-title":"Genomics of systemic lupus erythematosus: insights gained by studying monogenic young-onset systemic lupus erythematosus","volume":"43","author":"Hiraki","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1212\/NXI.0000000000000055","article-title":"Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL","volume":"2","author":"Schuh","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B87","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1002\/art.38824","article-title":"Identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by Whole-exome sequencing","volume":"66","author":"Ellyard","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ajmg.a.33778","article-title":"Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus","author":"Ravenscroft","year":"2011","journal-title":"Am J Med Genet A"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.jaci.2018.12.1012","article-title":"Novel proteasome assembly chaperone mutations in PSMG2\/PAC2 cause the autoinflammatory interferonopathy CANDLE\/PRAAS4","volume":"143","author":"de Jesus","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jaad.2009.04.046","article-title":"Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome","volume":"62","author":"Torrelo","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1210\/jc.2010-0488","article-title":"An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy","volume":"95","author":"Garg","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.3389\/fimmu.2019.02756","article-title":"Contribution of the unfolded protein response (UPR) to the pathogenesis of proteasome-associated autoinflammatory syndromes (PRAAS)","volume":"10","author":"Ebstein","year":"2019","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ajhg.2017.01.003","article-title":"De novo disruption of the proteasome regulatory subunit PSMD12 causes a syndromic neurodevelopmental disorder","volume":"100","author":"K\u00fcry","year":"2017","journal-title":"Am J Hum Genet"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.1224026","article-title":"Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency","volume":"337","author":"Bogunovic","year":"2012","journal-title":"Science"},{"key":"B95","doi-asserted-by":"publisher","first-page":"107633","DOI":"10.1016\/j.celrep.2020.107633","article-title":"Systemic type I IFN inflammation in human ISG15 deficiency leads to necrotizing skin lesions","volume":"31","author":"Fernandez","year":"2020","journal-title":"Cell Rep"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/BF00972817","article-title":"An unusual syndrome of widened medullary cavities of the metacarpals and phalanges, aortic calcification and abnormal dentition","volume":"1","author":"Singleton","year":"1973","journal-title":"Pediatr Radiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ajhg.2014.11.019","article-title":"Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome","volume":"96","author":"Jang","year":"2015","journal-title":"Am J Hum Genet"},{"key":"B98","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ajhg.2014.12.014","article-title":"A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome","volume":"96","author":"Rutsch","year":"2015","journal-title":"Am J Hum Genet"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/ajmg.a.38214","article-title":"Further evidence for specific IFIH1 mutation as a cause of Singleton-Merten syndrome with phenotypic heterogeneity","volume":"173","author":"Pettersson","year":"2017","journal-title":"Am J Med Genet A"},{"key":"B100","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"iii95","DOI":"10.1093\/rheumatology\/kez599","article-title":"Childhood vasculitis","volume":"59","author":"Ozen","year":"2020","journal-title":"Rheumatology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jamadermatol.2015.0251","article-title":"Stimulator of interferon genes-associated vasculopathy with onset in infancy: a mimic of childhood granulomatosis with polyangiitis","volume":"151","author":"Munoz","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12969-020-00425-w","article-title":"Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype","volume":"18","author":"Clarke","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"B104","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/ni.2948","article-title":"The SKIV2L RNA exosome limits activation of the RIG-Ilike receptors","volume":"15","author":"Eckard","year":"2014","journal-title":"Nat Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ni.3409","article-title":"DNA polymerase-alpha regulates the activation of type I interferons through cytosolic RNA:DNA synthesis","volume":"17","author":"Starokadomskyy","year":"2016","journal-title":"Nat Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10875-016-0271-8","article-title":"Copa syndrome: a novel autosomal dominant immune dysregulatory disease","volume":"36","author":"Vece","year":"2016","journal-title":"J Clin Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10875-016-0359-1","article-title":"Assessment of type I interferon signaling in pediatric inflammatory disease","volume":"37","author":"Rice","year":"2017","journal-title":"J Clin Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1038\/s41598-018-33062-1","article-title":"A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features","volume":"8","author":"El-Sherbiny","year":"2018","journal-title":"Sci Rep"},{"key":"B109","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/jir.2017.0127","article-title":"Development of a validated interferon score using NanoString Technology","volume":"38","author":"Kim","year":"2018","journal-title":"J Interferon Cytokine Res"},{"key":"B110","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/diagnostics9030113","article-title":"An easy and reliable strategy for making type I interferon signature analysis comparable among research centers","volume":"9","author":"Pin","year":"2019","journal-title":"Diagnostics"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1172\/JCI129301","article-title":"Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases","volume":"130","author":"de Jesus","year":"2020","journal-title":"J Clin Invest"},{"key":"B112","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11926-018-0743-3","article-title":"Therapeutic approaches to type I interferonopathies","volume":"20","author":"Bienias","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.26226\/morressier.57bc1755d462b80290b4d6b9","article-title":"Efficacy of the Janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children","volume":"138","author":"Fr\u00e9mond","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jaci.2016.10.030","article-title":"Tofacitinib relieves symptoms of stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173","volume":"139","author":"Seo","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/art.40805","article-title":"Efficacy of baricitinib in the treatment of chilblains associated with Aicardi-Gouti\u00e8res syndrome, a type I interferonopathy","volume":"71","author":"Meesilpavikkai","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J Clin Invest"},{"key":"B117","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/cpt.936","article-title":"Pharmacokinetics, pharmacodynamics, and proposed dosing of the oral JAK1 and JAK2 inhibitor baricitinib in pediatric and young adult CANDLE and SAVI patients","volume":"104","author":"Kim","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"B118","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1742-4690-8-91","article-title":"An autoimmune disease prevented by anti-retroviral drugs","volume":"8","author":"Beck-Engeser","year":"2011","journal-title":"Retrovirology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.stem.2017.07.009","article-title":"Modeling of TREX1-dependent autoimmune disease using human stem cells highlights L1 accumulation as a source of neuroinflammation","volume":"21","author":"Thomas","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1056\/NEJMc1810983","article-title":"Reverse-transcriptase inhibitors in the Aicardi-Gouti\u00e8res syndrome","volume":"379","author":"Rice","year":"2018","journal-title":"N Engl J Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/14397595.2019.1583832","article-title":"Safety and tolerability of sifalimumab, an anti-interferon-\u03b1 monoclonal antibody, in Japanese patients with systemic lupus erythematosus: a multicenter, phase 2, open-label study","volume":"30","author":"Takeuchi","year":"2020","journal-title":"Mod Rheumatol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1073\/pnas.1815365116","article-title":"HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2","volume":"116","author":"Cao","year":"2019","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.631329\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T04:34:22Z","timestamp":1617165262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.631329\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":123,"alternative-id":["10.3389\/fped.2021.631329"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.631329","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"article-number":"631329"}}